Orchard Therapeutics

Orchard Therapeutics

  • Founded in 2016
  • 201-500 Employees
  • $150M Post-IPO Equity on 2021-02

Careers at Orchard Therapeutics


About Orchard Therapeutics

Orchard Therapeutics is a biopharmaceutical company pioneering in the development and commercialization of transformative therapies for individuals with severe genetic diseases. The company is focusing on Hematopoietic Stem Cell (HSC) gene therapy, aiming to address unmet medical needs by offering potentially curative treatment options. With a commitment to improving lives significantly impacted by genetic conditions like metachromatic leukodystrophy, Orchard Therapeutics strives to change the treatment paradigm through innovative scientific research and dedication to patients' well-being.